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Introduction
About 95% of Down syndrome cases are due to simple
trisomy 21 with an extra free chromosome 21, 1–2%
are due to mosaicism, and 4% are due to unbalanced
heterologous or homologous acrocentric rearrange-
ments, of which rea(21q21q) and rob(14q21q) are
most common and occur with equal frequencies [1].
In heterologous Robertsonian translocation Down
syndrome, rob(14q21q) accounts for 82% of the cases
while rob(13q21q), rob(15q21q) and rob(21q22q)
account for the remaining cases [1]. Prenatal diag-
nosis by amniocentesis of recurrent Down syndrome
due to unbalanced homologous acrocentric rearrange-
ments is uncommon (Figures 1–3). Here, we report six
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SUMMARY
Objective: To present our experience of amniocentesis for the prenatal diagnosis of Down syndrome due to
unbalanced homologous acrocentric rearrangements and its recurrence in subsequent pregnancies.
Case Report: From January 1987 to September 2009, six cases with rea(21q21q) Down syndrome were diagnosed
among 31,194 patients who underwent amniocentesis at Mackay Memorial Hospital, Taipei, Taiwan. Cytogenetic
analysis of parental blood lymphocytes was performed in each case, and polymorphic DNA markers were used to
investigate the nature of the aberrant chromosome. Three of the six cases were associated with recurrence in subse-
quent pregnancies. The rea(21q21q) Down syndrome was associated with advanced maternal age in three cases, 
a previous child with rea(21q21q) Down syndrome in three cases, an abnormal maternal serum screening result
in one case, and an abnormal ultrasound finding in one case. All six cases arose de novo. Among the six cases with
molecular analysis results, all had isochromosome 21, five of which were determined to be of maternal origin.
Conclusion: We found a frequency of 0.019% for rea(21q21q) Down syndrome in patients undergoing amnio-
centesis. Down syndrome caused by the homologous rearrangement rea(21q21q) can be associated with recur-
rence. Prenatal diagnosis of rea(21q21q) Down syndrome should include extensive cytogenetic and molecular
analyses of the parents and probands. [Taiwan J Obstet Gynecol 2009;48(4):403–407]
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Figure 1. Typical karyotype of rea(21q21q) Down syndrome.
cases of rea(21q21q) Down syndrome diagnosed
among 31,194 patients who underwent amniocentesis
at Mackay Memorial Hospital, Taipei, Taiwan, during
the period between January 1987 and September 2009.
Reasons for amniocentesis included advanced maternal
age, abnormal ultrasound findings, abnormal maternal
serum screening results, a previous child with congeni-




This was the fourth pregnancy of a 35-year-old, gravida
4, para 2, woman. Amniocentesis was performed at 17
weeks’ gestation because of advanced maternal age
and a previous child with rea(21q21q) Down syn-
drome. The woman had experienced one previous
abortion. She had a 5-year-old daughter affected with
homologous Robertsonian translocation Down syn-
drome and a 3-year-old normal daughter with a 46,XX
karyotype. Polymorphic DNA marker analysis of the
affected daughter showed that the rea(21q21q) was
isochromosome 21 and was of maternal origin (Figure
2). The karyotype was 46,XX,i(21)(q10). Parental kary-
otypes derived from blood lymphocytes were normal.
Amniocentesis during the current pregnancy revealed
recurrent rea(21q21q) Down syndrome. Polymorphic
DNA marker analysis showed that the rea(21q21q)
was isochromosome 21 and was of maternal origin
(Figure 2). The karyotype was 46,XY,i(21)(q10). The
pregnancy was subsequently terminated. The karyotype
of cord blood lymphocytes was 46,XY,i(21)(q10). Her
fifth pregnancy resulted in a normal male baby with a
46,XY karyotype.
Case 2
This was the second pregnancy of a 36-year-old, gravida
2, para 1, woman. Amniocentesis was performed at
16 weeks’ gestation because of advanced maternal age
and a previous child with rea(21q21q) Down syn-
drome. She had a 2-year-old daughter affected with
rea(21q21q) Down syndrome. Polymorphic DNA marker
analysis showed that the rea(21q21q) was isochromo-
some 21 and was of maternal origin (Figure 3). The
karyotype was 46,XX,i(21)(q10). The parental kary-
otypes derived from blood lymphocytes were normal.
Amniocentesis during this pregnancy revealed recur-
rent rea(21q21q) Down syndrome. The pregnancy was
subsequently terminated. The karyotype of skin fibro-
blasts was 46,XX,i(21)(q10).
Case 3
This was the first pregnancy of a 25-year-old, gravida 1,
para 0, woman. Amniocentesis was performed at 
19 weeks’ gestation because of an increased maternal
serum Down screening risk of 1/115. Amniocentesis
revealed rea(21q21q) Down syndrome. The parental
karyotypes derived from blood lymphocytes were nor-
mal. Polymorphic DNA marker analysis showed that
the rea(21q21q) was isochromosome 21 and was of
maternal origin. The karyotype was 46,XX,i(21)(q10).
The pregnancy was subsequently terminated. The
karyotype of cord blood lymphocytes was 46,XX,i(21)
(q10). Her second pregnancy resulted in a normal male
co-twin with a 46,XY karyotype and a normal female
co-twin with a 46,XX karyotype.
Case 4
This was the first pregnancy of a 30-year-old, gravida 1,
para 0, woman. Amniocentesis was performed at 18
weeks’ gestation because of increased nuchal thickness.
Amniocentesis revealed rea(21q21q) Down syndrome.
The parental karyotypes derived from blood lympho-
cytes were normal. Polymorphic DNA marker analysis
showed that the rea(21q21q) was isochromosome 
21 and was of maternal origin. The karyotype was
46,XX,i(21)(q10). The pregnancy was subsequently
terminated. The karyotype of cord blood lymphocytes
was 46,XX,i(21)(q10).
Case 5
This was the first pregnancy of a 34-year-old, gravida
1, para 0, woman. Amniocentesis was performed at 
19 weeks’ gestation because of advanced maternal age.
Amniocentesis revealed rea(21q21q) Down syndrome.
The parental karyotypes derived from blood lympho-
cytes were normal. Polymorphic DNA marker analysis
showed that the rea(21q21q) was isochromosome 21
and was of maternal origin. The karyotype was 46,XX,
i(21)(q10). The pregnancy was subsequently terminated.
Case 6
This was the second pregnancy of a 26-year-old, gravida
2, para 1, woman. Amniocentesis was performed at
15 weeks’ gestation because of a previous fetus with
rea(21q21q) Down syndrome. The fetus of her first
pregnancy had rea(21q21q) Down syndrome with 
a 46,XX,+21, der(21;21)(q10;q10) karyotype, which
was diagnosed by amniocentesis 2 years prior to the 
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Figure 2. Representative electrophoretograms of the family
members of Case 1 with recurrent rea(21q21q) Down syn-
drome showing isochromosome 21 Down syndrome of mater-
nal origin in the affected daughter (Proband 1) and in the
affected fetal son (Proband 2). Using the microsatellite marker
D21S1437, one maternally originated 122-bp allele and one
paternally originated 134-bp allele are seen in Proband 1, and
one maternally originated 122-bp allele and one paternally
originated 130-bp allele are seen in Proband 2. The two peaks
(maternal to paternal ratio, 122:134) of unequal fluorescence
activity with a ratio of 2:1 in Proband 1 and two peaks (mater-
nal to paternal ratio, 122:130) of unequal fluorescence activity















Figure 3. Representative electrophoretograms of the family
members of Case 2 with recurrent rea(21q21q) Down syn-
drome showing isochromosome 21 Down syndrome of mater-
nal origin in the affected daughter (Proband 1) and in the
affected fetal daughter (Proband 2). Using the microsatellite
marker D21S2052, one maternally originated 138-bp allele
and one paternally originated 146-bp allele are seen in
Proband 1, and one paternally originated 130-bp allele and
one maternally originated 138-bp allele are seen in Proband
2. The two peaks (maternal to paternal ratio, 138:146) of
unequal fluorescence activity with a ratio of 2:1 in Proband 1
and two peaks (paternal to maternal ratio, 130:138) of un-
equal fluorescence activity with a ratio of 1:2 in Proband 2
indicate a maternal origin for isochromosome 21.
current pregnancy because of a maternal Down syn-
drome serum screening risk of 1/111. At that time, the
parental karyotypes derived from blood lymphocytes
were normal. The pregnancy was subsequently termi-
nated. Amniocentesis during the current pregnancy
revealed recurrent rea(21q21q) Down syndrome.
Polymorphic DNA marker analysis showed that the
rea(21q21q) was isochromosome 21. The parental
origin was not determined, because parental DNA was
not obtained. The karyotype was 46,XY,i(21)(q10).
The pregnancy was subsequently terminated. Her third
pregnancy resulted in a normal female baby with a 46,XX
karyotype, following preimplantation genetic diagnosis
and amniocentesis.
Discussion
Chen et al [2] previously reported a frequency of chro-
mosome aberrations of 2.53% among 166,419 amnio-
centeses, and about 30% of the detected aneuploidies
were Down syndrome. In this report, we found a fre-
quency of 0.019% for rea(21q21q) Down syndrome
among patients who underwent amniocentesis. We
determined that rea(21q21q) Down syndrome could
be associated with advanced maternal age (Cases 1, 2
and 5), a previous child with rea(21q21q) Down syn-
drome (Cases 1, 2 and 6), an abnormal maternal
serum screening result (Case 3) or an abnormal ultra-
sound finding (Case 4), and that the homologous
rearrangement rea(21q21q) Down syndrome could 
be associated with recurrence.
Homologous rearrangement rea(21q21q) Down
syndrome includes isochromosome 21 i(21q) Down
syndrome and homologous Robertsonian translocation
rob(21q21q) Down syndrome. More than 95% of
rea(21q21q) Down syndrome cases arise de novo [3]. In
isochromosome 21 Down syndrome, i(21q) is derived
from a single chromosome 21; whereas in homologous
Robertsonian translocation Down syndrome, rob
(21q21q) is derived from two different homologous
chromosome 21 [3,4]. Conventional cytogenetic analy-
sis is unable to distinguish between rob(21q21q) and
i(21q), and molecular technology using polymorphic
DNA markers is required to make this distinction.
The majority of cases with rea(21q21q) Down syn-
drome reported to date have been of i(21q) Down
syndrome [3–6]. In a meta-analysis of 34 cases of rea
(21q21q) Down syndrome based on three reports
[3,5,6], Kovaleva and Shaffer [7] found that 30 cases
(88.2%) were i(21q) Down syndrome, and four (11.8%)
were rob(21q21q) Down syndrome. The incidence of
maternally derived i(21q) has been noted to be similar
to that of paternally derived i(21q) [3,5,8,9]. Most cases
with i(21q) showed no recombination, consistent with a
postzygotic mitotic event [4,10,11], whereas only a
few showed recombination consistent with a meiotic
event [3,9].
All six of the current cases arose de novo. These six
cases underwent molecular analysis and demonstrated
isochromosome 21, five of which were determined 
to be of maternal origin. These cases were likely to 
be the results of mitotic events. The recurrence of
rea(21q21q) Down syndrome in Cases 1, 2 and 6 is of
interest. Recurrence of rea(21q21q) Down syndrome
has been shown to be associated with low-level parental
mosaicism or gonadal mosaicism. Kovaleva and Shaffer
[7] found that parents of rea(21q21q) Down syndrome
offspring more often demonstrated mosaicism. They
found a sevenfold increase in the number of mosaic
cases in parents of rea(21q21q) Down syndrome off-
spring compared with parents of non-rea(21q21q)
offspring. Kovaleva and Shaffer [7] suggested that
extensive parental analysis for mosaicism should be
undertaken in cases of recurrent rea(21q21q) Down
syndrome. The recurrence rate for de novo rea(21q21q)
Down syndrome has been reported to be low. In a
study of 112 families with a child with de novo 21q21q
translocation Down syndrome, Steinberg et al [12]
found that none of the parents had a second child
with Down syndrome, and three of 112 sets of parents
had low-grade mosaicism for a 21q21q translocation.
However, three of the six cases (50%) in our study were
associated with recurrence. In the families with recurrent
de novo rea(21q21q) Down syndrome, several reports
have demonstrated mosaicism for rea(21q21q) in the
skin or ovary of one parent but normal karyotypes in
the parental blood lymphocytes [13–17] and very low
levels of rea(21q21q) mosaicism in the blood lympho-
cytes of one parent [18]. Parental cytogenetic studies of
tissues, as well as blood, could therefore be helpful for
detecting low percentage mosaicism in the parents of
families with recurrent Down syndrome. Preimplanta-
tion genetic screening using fluorescence in situ hybridiza-
tion or comparative genomic hybridization for the
analysis of chromosomes in preimplantation embryos
may provide parents with the chance of starting a preg-
nancy knowing that the baby will be free of Down syn-
drome. The recurrence of familial rea(21q21q) Down
syndrome in pregnancies of couples in whom one of
the partners is a carrier of balanced rea(21q21q) is
100%. In such cases, genetic counseling should include
advice to refrain from further pregnancies, the use of
artificial insemination with normal donor sperm (in
case of a male carrier), or the use of normal donor ova
(in case of a female carrier).
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